Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China
· Delayed Price · Currency is CNY 22.80
+0.18 (0.80%)
Apr 29, 2026, 3:04 PM CST
SHE:002287 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 12,983 | 13,473 | 11,346 | 11,924 | 12,061 | 16,133 | Upgrade
|
| Market Cap Growth | 7.55% | 18.75% | -4.85% | -1.14% | -25.24% | 17.84% | Upgrade
|
| Enterprise Value | 11,183 | 11,487 | 9,899 | 11,823 | 11,263 | 15,564 | Upgrade
|
| Last Close Price | 22.80 | 23.66 | 20.65 | 21.17 | 21.15 | 27.61 | Upgrade
|
| PE Ratio | 18.85 | 20.78 | 19.49 | 20.52 | 25.52 | 22.54 | Upgrade
|
| Forward PE | - | 43.51 | 43.51 | 43.51 | 43.51 | 43.51 | Upgrade
|
| PS Ratio | 5.37 | 5.58 | 4.85 | 5.83 | 5.90 | 9.11 | Upgrade
|
| PB Ratio | 2.55 | 2.70 | 2.76 | 3.16 | 3.56 | 5.01 | Upgrade
|
| P/TBV Ratio | 2.74 | 2.90 | 3.04 | 3.54 | 4.07 | 5.83 | Upgrade
|
| P/FCF Ratio | 70.05 | 23.37 | 56.36 | 26.00 | 907.60 | 17.74 | Upgrade
|
| P/OCF Ratio | 41.83 | 18.46 | 24.84 | 17.20 | 42.22 | 15.59 | Upgrade
|
| EV/Sales Ratio | 4.62 | 4.76 | 4.23 | 5.78 | 5.51 | 8.79 | Upgrade
|
| EV/EBITDA Ratio | 12.87 | 13.28 | 15.35 | 21.38 | 18.64 | 32.65 | Upgrade
|
| EV/EBIT Ratio | 15.40 | 15.74 | 18.44 | 25.29 | 21.34 | 37.37 | Upgrade
|
| EV/FCF Ratio | 60.33 | 19.92 | 49.17 | 25.78 | 847.54 | 17.11 | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.19 | 0.41 | 0.41 | 0.50 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 0.93 | 1.07 | 2.59 | 2.74 | 2.78 | 3.01 | Upgrade
|
| Debt / FCF Ratio | 4.36 | 1.61 | 8.44 | 3.35 | 127.68 | 1.60 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.40 | -0.32 | -0.22 | -0.15 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.13 | -2.33 | -2.01 | -1.50 | -0.84 | -1.06 | Upgrade
|
| Net Debt / FCF Ratio | -9.97 | -3.50 | -6.45 | -1.81 | -37.99 | -0.56 | Upgrade
|
| Asset Turnover | 0.36 | 0.35 | 0.36 | 0.34 | 0.36 | 0.35 | Upgrade
|
| Inventory Turnover | 1.43 | 1.71 | 2.46 | 2.29 | 2.64 | 2.53 | Upgrade
|
| Quick Ratio | 2.71 | 2.30 | 2.37 | 2.40 | 2.23 | 2.12 | Upgrade
|
| Current Ratio | 3.12 | 2.57 | 2.50 | 2.57 | 2.35 | 2.25 | Upgrade
|
| Return on Equity (ROE) | 14.55% | 14.22% | 14.75% | 16.18% | 14.21% | 24.28% | Upgrade
|
| Return on Assets (ROA) | 6.79% | 6.65% | 5.13% | 4.79% | 5.76% | 5.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 20.49% | 22.05% | 16.78% | 14.44% | 17.06% | 15.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.60% | 13.90% | 10.50% | 9.30% | 11.70% | 9.80% | Upgrade
|
| Earnings Yield | 5.14% | 4.81% | 5.13% | 4.87% | 3.92% | 4.44% | Upgrade
|
| FCF Yield | 1.43% | 4.28% | 1.77% | 3.85% | 0.11% | 5.64% | Upgrade
|
| Dividend Yield | 1.95% | - | 1.84% | 2.27% | 1.84% | 2.14% | Upgrade
|
| Payout Ratio | 50.84% | 69.87% | 48.51% | 37.86% | 72.06% | 27.31% | Upgrade
|
| Buyback Yield / Dilution | -4.12% | -2.50% | -0.03% | 0.05% | -0.21% | -0.12% | Upgrade
|
| Total Shareholder Return | -2.16% | -2.50% | 1.81% | 2.31% | 1.63% | 2.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.